Company Filing History:
2 out of 1,500 
1 out of 23 
1 out of 7 Years Active: 1997-2007
Title: Innovations by Thomas Profitlich: Pioneering Stable Drug Formulations
Introduction
Thomas Profitlich, an accomplished inventor based in Munich, Germany, has made significant contributions to the field of pharmaceutical sciences. With a robust portfolio consisting of four patents, he has focused on developing innovative solutions that enhance the stability and efficacy of drug formulations. His expertise in this area is reflected in his latest groundbreaking inventions.
Latest Patents
Among Thomas's recent contributions is a patent for a stable drug form for oral administration that utilizes benzimidazole derivatives as the active ingredient. This invention not only addresses the efficacy of the medication but also includes a process for its preparation, ensuring that patients receive a reliable and effective treatment. The stable medicament designed by Profitlich signifies a notable advancement in drug formulation, providing healthcare providers and patients with improved therapeutic options.
Career Highlights
Throughout his career, Thomas Profitlich has been associated with leading pharmaceutical companies such as AstraZeneca AB and Klinge Pharma GmbH. His work at these organizations has positioned him as a key player in the development of innovative drug formulations and has allowed him to collaborate with some of the top minds in the industry.
Collaborations
In his professional journey, Profitlich has collaborated with notable colleagues, including Kersten Walter and Gerd-Ulfert Heese. These partnerships have undoubtedly contributed to the successful development and implementation of his inventive concepts, fostering an environment of innovation and creativity within the pharmaceutical field.
Conclusion
Thomas Profitlich's inventive spirit and dedication to improving drug formulations have solidified his reputation as a leading innovator in the pharmaceutical industry. His latest patents not only demonstrate his technical prowess but also hold promise for enhancing patient care through reliable and effective medication. As he continues to push the boundaries of innovation, the healthcare industry eagerly anticipates the future advancements that his work will bring.